Connect with us

Government

“Obviously, This Is Very Bad News For Biden”: Wall Street Reacts To Today’s Red Hot Inflation Print

"Obviously, This Is Very Bad News For Biden": Wall Street Reacts To Today’s Red Hot Inflation Print

Coming into today’s CPI number, which…

Published

on

"Obviously, This Is Very Bad News For Biden": Wall Street Reacts To Today's Red Hot Inflation Print

Coming into today's CPI number, which followed three previous red-hot inflation prints, we said that it's time for a "miss" (the first of 2024) not because the data demands it - on the contrary, prices continue to rise at a frightening pace - but because a dovish CPI print today would be the last opportunity for the Fed to set a timetable for a rate cut calendar ahead of November's election.

Well, you can wave goodbye to all that, because we just got the 4th consecutive "inflation beat" in a row...

... with supercore inflation coming in blazing hot...

... thanks to a boiling inflation print which saw every single CPI metric coming in hotter than expected - was a shock, not because it reflected reality, but because it effectively sealed Biden's fate because as Bloomberg's Chris Antsey writes, "obviously, this is very bad news for Joe Biden... we’re approaching the point where high inflation is bound to still be in voters’ minds when they head to the polls, regardless of how the price figures come in over summer."

With that in mind, here is a snapshot of kneejerk reactions by various other Wall Street economists and strategists to today's print courtesy of Bloomberg.

Morgan Stanley economist Ellen Zentner is the first sellside to warn her June rate-cut call is in jeopardy:

“The upside surprise in core CPI is moving the inflation data further away from the convincing evidence the Fed needs to start cutting in June. Dependent on the PPI data tomorrow, this print tilts the Fed toward a later start to the cutting cycle than our current forecast for June.”

Brian Coulton, chief economist at Fitch:

“The so-called ‘Super-core’ CPI  measure – services excluding rents – jumped from 3.9% y/y in February to 4.8% in March. This latter metric is heading the wrong way and quite quickly at that.”

David Kelly, Chief Global Strategist at JPMorgan asset management:

“I wish the Federal Reserve would pay more attention to what they do to financial markets with their manipulation of interest rates and not worry too much about what they are doing to the economy. Last decade, we mispriced housing terribly and now a large chunk of younger Americans can’t buy a house.”

Anna Wong, Bloomberg economist:

“March is a month where the CPI enters a seasonal window that’s favorable for disinflation. The fact that core CPI remained the same in March as February — even if it maps to about 0.3% in core PCE inflation terms – is not a good development. This report, more than February’s, is likely to feed Fed concern that progress on disinflation is stalling — even though the core print for the two months was the same.”

Marvin Loh, State Street economist:

“While the rent component shows a strong disinflationary trend, the more important owner’s occupied component is stubbornly unchanged and well above what is needed to get towards a stable 2% level.”

Ira Jersey, Bloomberg rates strategist:

“The 3-month annualized core CPI climbing to 4.5% is going to keep early Fed-cut calls muted coming up. 50 bps of cuts in 2024 currently being priced may not occur until later in the year. The yield curve flattening isn’t surprising as we continue to price out early and deep cuts.”

* * *
“The timing of 2024 rate-cut expectations are front of mind for market participants, with linear markets pricing just below even odds of a first cut in July. Still, the stickiness of ‘supercore’ inflation, now north of 8% on a 3-month annualized basis, may continue to put upward pressure on expectations of the Fed’s terminal floor.”

* * *

“A retest of 4.51% is nearly assured with the higher-than-expected CPI. If that doesn’t hold, 4.7% is the next stopping spot for the 10-year yield.”

Seema Shah, economist at Principal Asset Management:

"Today’s print sealed the fate for the June FOMC meeting with a hike now very unlikely. In fact, even if inflation were to cool next month to a more comfortable reading, there is likely sufficient caution within the Fed now to mean that a July cut may also be a stretch, by which point the US election will begin to heavily intrude with Fed decision making.”

Priya Misra, JPM rates strategist:

”This was a pivotal report for the market since the last 2 reports were a little high (0.4% mom) and the Fed viewed those readings as a ‘bump in the road’ rather than a change in the trend towards inflation moderation.Rates have risen in the last few weeks as cuts have been priced out but there is more room to go. I also think risk assets will be sensitive to rates if the 10y moves above 4.5%. So far risk assets could ignore the high inflation prints since the Fed was dismissing it. But I think that changes now... Most of the strength in the core explained by firmer motor vehicle insurance costs and medical care -- both of these do not feed into the core PCE deflator in the same way. So incoming Fedspeak will be very important”

Lindsay Rosner, head of multi-sector fixed income investing at Goldman Asset Management:

“To be clear, this number did not eclipse the Fed’s confidence; it did, however, cast a shadow on it. When it comes to spread risk, one hotter CPI print does not derail the bigger story which is the economy is strong, defaults remain benign, and the technicals continue to cast sunshine on spreads maintaining this range.”

Erik Norland, chief economist at the CME Group:

"Given the recent trend in fuel prices, there’s a risk that headline inflation readings on a year-on-year basis surpass 4%. The narrative up to now has been danger of sticky 3% but few are talking about a reacceleration to the 4s.

Florian Ielpo at Lombard Odier Asset Management:

“If the Fed remains committed to its ‘one cut in June’ stance, real interest rates could remain stable while inflation compensation may increase. This would be supportive for equities, as real financing conditions would not tighten further, and profit margins could benefit from higher-than-expected inflation.”

Torsten Slok of Apollo Global

“Easy financial conditions continue to provide a significant tailwind to growth and inflation. As a result, the Fed is not done fighting inflation and rates will stay higher for longer.”

It's about to get even worse: recall today we have a $39 billion 10-year auction which is already being dubbed “sloppy” and a definitive break of 4.5% could easily extend if underwriting dealers are left holding the bag. As it stands, the 10yr has popped above the 4.5% parapet. Ian Lyngen at BMO Capital Markets says:

“We expect the setup to the auction will break 4.50% in 10-year yields with ease.”  

And George Goncalves, head of US macro strategy at MUFG, adds:

“Price action tells you two things - positioning wasn’t as concentrated or in line with the mini rally we had heading into the number over the last 24hrs and at same time very little in auction setup either.. . Bottomline if no dip buyers show up this morning, and we keep drifting, the risk is a 4.5% this afternoon.”

* * *

The bottom line, as Bloomberg's Sebatian Boyd writes is the following:

"today’s CPI print adds to the evidence that US monetary policy just isn’t as restrictive as the Federal Reserve thinks it is, and that interest rates will therefore need to stay higher for longer. There are lots of reasons that might be: The great resignation during the pandemic may well have heightened productivity in the US economy as people found new jobs where they’re a better fit. Higher government spending would also push up the neutral rate of interest. But every time we get a hot indicator, the case builds that it has happened and that conventional measures of neutral interest rates are too low. If that is the case, the upshot is higher yields and a flatter curve, because not only would the Fed be able to cut by less than expected in the short term, but yields will need to be higher in the long term too."

Finally, we conclude where we started, and echoing what we said in our CPI preview, namely that the BLS had Biden's fate in its hands, it appears the bureaucrats just voted for Trump. Here is BBG's Chris Antsey:

Obviously, this is very bad news for Joe Biden. It’s still only April, and we’ll have another half-a-year’s worth of inflation reports before the election. But we’re approaching the point where high inflation is bound to still be in voters’ minds when they head to the polls, regardless of how the price figures come in over summer.

To underscore how calamitous today's data is for Biden, here also is BBG's Enda Curran:

Let’s be clear -- today’s data has both economic and political implications. The economics are straight forward: It looks unlikely that the Fed will be cutting rates near term (barring a shock). The political implications are less clear but no less meaningful: Poll after poll has found that voters are grumpy on the economy and news that it could be a while yet before the inflation story is over won’t brighten their mood.

And with Biden's goose now thoroughly cooked, the next question is how long before somebody raises the possibility of a rate hike.

Tyler Durden Wed, 04/10/2024 - 09:36

Read More

Continue Reading

International

CAMH develops first ever clinically validated natural supplement to prevent postpartum blues

A new study published in the Lancet discovery science  journal eClinicalMedicine has confirmed that a novel natural supplement—invented, researched,…

Published

on

A new study published in the Lancet discovery science  journal eClinicalMedicine has confirmed that a novel natural supplement—invented, researched, developed and commercialized at the Centre for Addiction and Mental Health (CAMH)—prevents postpartum blues, and reduces symptoms of postpartum depression over the following six months after giving birth.

Credit: Image courtesy of CAMH. All rights reserved.

A new study published in the Lancet discovery science  journal eClinicalMedicine has confirmed that a novel natural supplement—invented, researched, developed and commercialized at the Centre for Addiction and Mental Health (CAMH)—prevents postpartum blues, and reduces symptoms of postpartum depression over the following six months after giving birth.

Up to 8 out of ten new mothers experience postpartum, or ‘baby,’ blues, characterized by mood swings, crying spells, anxiety and difficulty sleeping. The condition usually begins within the first few days after delivery and may last for up to two weeks. Postpartum blues strongly raises the risk of postpartum depression, a serious mental illness affecting 13 per cent of mothers. Postpartum depression has important health care consequences: impairing quality of life, increasing risk for future depressive episodes and suicide, and is associated with cognitive and emotional effects in children. Until now, options for widespread prevention have been lacking for either condition.

The study, entitled Dietary Supplement for Mood Symptoms in Early Postpartum: A Double-Blind Randomized Placebo Controlled Trial, involved more than 100 postpartum participants between January 2019 and December 2022 who either took four doses of the natural supplement several days after giving birth, or a matching placebo. Within the supplement group, two-thirds (66 per cent) experienced either no symptoms or only negligible symptoms of postpartum blues. Furthermore, in the following six months, participants who received the supplement experienced less symptoms of depression with none reaching the clinical threshold of postpartum depression six months after giving birth.

“Globally 140 million births take place every year. Most women then experience postpartum blues, which, when severe, increases the likelihood of getting full-blown postpartum depression at least fourfold. Our study showed that both postpartum blues and later symptoms of depression were lower in women who received the dietary supplement,” said Dr. Jeffrey Meyer, inventor of the nutraceutical and study senior author. “Providing this specialized dietary support in the first few days after giving birth is a crucial window to avoid depressive symptoms which is tremendously important given there is considerable risk that they may recur and have lifelong impact.”

Dr. Meyer has been investigating postpartum blues for more than 15 years. His previous imaging research found that a protein called MAO-A rises dramatically in the brains of postpartum women and this protein removes important brain chemicals—like serotonin and dopamine—that support normal mood. It also acts as an oxidant and is linked to the development and progression of certain mental illnesses. To combat this effect, the nutraceutical is made up of a patented unique combination of natural ingredients, including blueberry extract, which contain antioxidants, and amino acids that replenish essential neurochemicals in the brain to support healthy mood and the ability to concentrate under stress. The supplement was well tolerated and women who took it tended to report less symptoms, in part due to less drowsiness, headache and restlessness. The researchers previously showed that the amino acids in the supplement do not affect their total concentrations in breast milk, which was expected since these amino acids are already found in proteins in breast milk.     

CAMH has partnered with international women’s health supplement and pharmaceutical company Exeltis via a licensing agreement to bring the product to market under the name Blues Away®. Exeltis has maintained the natural health product approach in their preparations and manufacture for widespread distribution of the supplement. It is expected that the product will be available for sale in the U.S. beginning April 11, 2024.  It is also in the process of being brought to other global markets—including Canada—with the pace of approvals being dependent on each country’s regulatory requirements and reviews. 

“We are thrilled to unveil the culmination of years of dedication and collaboration in the form of our groundbreaking nutraceutical for postpartum blues prevention. It is great that we are able to simultaneously share our clinical research around this product while also partnering with a  global women’s health industry leader to make it available to the new mothers who need it,” said Klara Vichnevetski, Director of Industry Partnerships and Technology Transfer. CAMH has nurtured this innovation from its inception, guiding it from bench to bedside where it can make an immediate and profound difference in the lives of millions of women and their families.”

A limitation of the study was that, of the several measures of depression in the study, the supplement did not demonstrate the expected protective effect in an experimental test that involves inducing low mood with sad stimuli, although it is possible that the stress of the COVID-19 pandemic and moving the setting of the study to participant’s homes during the pandemic may have influenced the results of this particular test.

Aristotle Voineskos, Vice President of Research, added: “Two major pillars of our CAMH approach to research are the importance of integrating scientific findings into advancing mental health care and the value of early intervention. Through the perseverance and dedication of our researchers and technology transfer team, this novel preventative therapy may contribute to best practice when it comes to postpartum care and help women around the world avoid more serious and chronic mental illness.”

This research was funded by CAMH, with some additional funding from Exeltis.

-30-

About the Centre for Addiction and Mental Health (CAMH)

CAMH is Canada’s largest mental health and addiction teaching hospital and a world leading research centre in this field. CAMH combines clinical care, research, education, policy development and health promotion to help transform the lives of people affected by mental illness and addiction. CAMH is fully affiliated with the University of Toronto, and is a Pan American Health Organization/World Health Organization Collaborating Centre. For more information, please visit camh.ca or follow @CAMHnews on Twitter.

Media Contact:

CAMH Media Relations
media@camh.ca


Read More

Continue Reading

Spread & Containment

‘Bird Flu-Pocalypse’ Forces Hong Kong To Suspend Some Imports Of US Poultry Meat

‘Bird Flu-Pocalypse’ Forces Hong Kong To Suspend Some Imports Of US Poultry Meat

The recent spread of bird flu—also known as highly pathogenic…

Published

on

'Bird Flu-Pocalypse' Forces Hong Kong To Suspend Some Imports Of US Poultry Meat

The recent spread of bird flu—also known as highly pathogenic avian influenza, or HPAI— across several US states has been hyped by corporate media. Some journalists are quoting 'experts' who warn the bird flu pandemic could be '100 times worse' than Covid.' 

According to Bloomberg data, the story count in corporate media for all things "Bird Flu" last week hit a record high on data going back to 2014. 

The context here is crucial. Bird flu is not just a US issue anymore; it's 'going global,' and this is happening just before the US presidential elections in November.  

On Tuesday, Hong Kong's food safety authority published a memo stating, "Import of poultry meat and poultry products suspended in some areas of the United States." 

Here's the full memo from the Center for Food Safety (CFS) of the Food and Environmental Hygiene Department:

The Center for Food Safety (CFS) of the Food and Environmental Hygiene Department announced today (April 9) that in response to a notification from the World Organization for Animal Health regarding an outbreak of highly pathogenic H5N1 avian influenza in Ionia County, Michigan, and Parmer County, Texas, USA, The CFS immediately instructed the trade to suspend the import of poultry meat and poultry products (including poultry eggs) from the above-mentioned areas to protect public health in Hong Kong.

A spokesman for the CFS said that according to the Census and Statistics Department, Hong Kong imported about 37,770 tonnes of chilled and frozen poultry meat and about 83.84 million poultry eggs from the United States last year.

The spokesman said: "The CFS has contacted the US authorities regarding the incident and will continue to closely monitor information on the outbreak of avian influenza from the World Organization for Animal Health and relevant authorities, and will take appropriate actions in light of the development of the local epidemic."

If it's bird flu or whatever "Disease X" could possibly be, there appears to be a push to "intersect" some type of 'Covid crisis' before the 2024 US elections.

"They will surely try to run their "Disease X" ruse. But they have already lost the trust of the people they made war against in their own country. In which case, expect resistance among the un-sick," James Howard Kunstler penned in a note earlier this month.

Tyler Durden Tue, 04/09/2024 - 21:20

Read More

Continue Reading

Government

15 US Agencies Knew Wuhan Lab Was “Trying To Create A Coronavirus Like COVID-19”: Rand Paul

15 US Agencies Knew Wuhan Lab Was "Trying To Create A Coronavirus Like COVID-19": Rand Paul

While a massive body of evidence exists on the…

Published

on

15 US Agencies Knew Wuhan Lab Was "Trying To Create A Coronavirus Like COVID-19": Rand Paul

While a massive body of evidence exists on the origins of COVID-19, Senator Rand Paul (R-KY) is conducting his own investigation into the matter.

In a Tuesday op-ed, Paul writes that government officials from 15 federal agencies "knew in 2018 that the Wuhan Institute of Virology was trying to create a coronavirus like COVID-19."

These officials knew that the Chinese lab was proposing to create a COVID 19-like virus and not one of these officials revealed this scheme to the public. In fact, 15 agencies with knowledge of this project have continuously refused to release any information concerning this alarming and dangerous research.

Government officials representing at least 15 federal agencies were briefed on a project proposed by Peter Daszak’s EcoHealth Alliance and the Wuhan Institute of Virology. -Rand Paul

Paul is talking about the DEFUSE project, which was revealed after DRASTIC Research uncovered documents showing that DARPA had been presented with a proposal for EcoHealth to perform gain-of-function research on bat coronavirus.

And according to Rand Paul, officials from 15 agencies knew about this. While the project was never funded (DARPA called it too dangerous) - Paul writes: "This project, the DEFUSE project, proposed to insert a furin cleavage site into a coronavirus to create a novel chimeric virus that would have been shockingly similar to the COVID-19 virus."

And what does this mean?

It means that at least 15 federal agencies knew from the beginning of the pandemic that EcoHealth Alliance and the Wuhan Institute of Virology were seeking federal funding in 2018 to create a virus genetically very similar if not identical to COVID-19.

Disturbingly, not one of these 15 agencies spoke up to warn us that the Wuhan Institute of Virology had been pitching this research. Not one of these agencies warned anyone that this Chinese lab had already put together plans to create such a virus.

Peter Daszak concealed this proposal. University of North Carolina scientist Ralph Baric, a named collaborator on the DEFUSE project, failed to reveal that the Wuhan Institute of Virology had already proposed to create a virus similar to COVID-19.

And now we know that 15 agencies heard the proposal and when each agency discovered that COVID-19 was strangely similar to DEFUSE’s proposed virus creation, not one agency head stepped forward to warn the public that the virus might be man-made and therefore already adapted to transmit freely among humans. -Rand Paul

Paul further writes that Fauci's NIAID was not only briefed on the DEFUSE proposal, his "Rocky Mountain Lab" was named as a partner in it along with the Wuhan Institute of Virology.

Meanwhile, researcher Ian Lipkin, one of the authors of the "proximal origins" coverup paper, was also part of the DEFUSE plan - which he never revealed publicly.

"Did NIAID warn us? Did Anthony Fauci warn us? No! All lips remained sealed," writes Paul.

Tyler Durden Tue, 04/09/2024 - 20:00

Read More

Continue Reading

Trending